数据来源：聚源 -19% -10% 0% 10% 19% 29% 38% 2024-12 2025-04 2025-08 汽车 沪深300 汽车研究团队 邓健全（首席分析师） 证书编号：S0790525090003 赵悦媛（联席首席分析师） 证书编号：S0790525100003 赵旭杨（分析师） 证书编号：S0790523090002 傅昌鑫（分析师） 证书编号：S0790525090005 汽车 2025 年 12 月 14 日 投资评级：看好（维持） 行业走势图 相关研究报告 《鸿蒙智行尊界 S800 轿车 11 月交付 破 2000 台，宇树科技完成 IPO 辅导— 行业周报》-2025.12.7 《特斯拉 FSD V14.2.1 上线，长安汽车 拟 2.25 亿元参与设立机器人公司—行 业周报》-2025.11.30 《小鹏汽车第 100 万台整车下线，广 州车展车企竞逐具身智能新赛道—行 业周报》-2025.11.23 "两新"政策有望优化实施，客车行业出口加速 ——行业周报 | 邓健全（分析师） | 赵悦媛（分析师） | 傅昌鑫（分析师） | | --- | --- | --- | | deng ...

（文章来源：证券日报） 证券日报网讯 12月11日，安凯客车在互动平台回答投资者提问时表示，截至2025年12月10日，公司股 东总户数为48515户。 ...

轻型客车则呈现同比下滑态势。11月产量261辆，累计产量1342辆，同比下降13.42%；11月销量70辆，累计销量1166辆，同比下降22.68%。 12月8日，安凯客车发布11月份产销情况自愿性信息披露公告。11月汽车产量为869辆，本年累计产量达7862辆，较去年同期增长64.37%；11 月销量为517辆，本年累计销量7570辆，同比增幅57.71%，整体产销态势稳健向好。 | | | | | 早1V: 物 | | | --- | --- | --- | --- | --- | --- | | 品 目 | 2025 年 11 月 | | 本年累计 | 累计数量较去年同期 增减比率 | | | 产量 | | 869 | 7862 | | 64. 37% | | 其中:大型客车 | | 149 | 3875 | 191. 35% | | | 中型客车 | | 459 | 2645 | | 38. 99% | | 轻型客车 | | 261 | 1342 | -13.42% | | | 销量 | | 517 | 7570 | | 57.71% | | 其中:大型客车 | | 76 | 3744 | 200. ...

Group 1 - Weidi Co., Ltd. plans to acquire control of Jiuxing Precision Technology, which is expected to constitute a major asset restructuring. The company will pay cash to acquire 51% of the equity from Jiangsu Zhiyue Tiancheng Enterprise Management Co., Ltd. and Jiuxing Precision Technology, aiming to gain at least 51% voting rights [2] - Purun Co., Ltd. intends to purchase 49% equity of high-performance storage company Noah Changtian through issuing shares, convertible bonds, and cash payments. Upon completion, Purun will hold 100% of Noah Changtian, which specializes in high-performance 2D NAND and derivative storage products [3] - ST Yishite is undergoing a significant share transfer, with Jiangjiang Industrial Group acquiring 4.34 billion shares, representing 18.66% of the total share capital, at a price of 5.61 yuan per share, totaling 2.437 billion yuan [5] Group 2 - Midea Group has completed its share repurchase plan, buying back 135 million shares, accounting for 1.76% of the total share capital, with a total expenditure of approximately 10 billion yuan [6] - Jingji Agricultural plans to repurchase shares using self-raised funds, with a total amount between 100 million and 200 million yuan, at a maximum price of 23.7 yuan per share [6] - Helen Zhe intends to repurchase shares with a total amount between 50 million and 100 million yuan, at a maximum price of 7.5 yuan per share [7] Group 3 - Shengda Resources plans to acquire 60% equity of Yichun Jinshi Mining for 500 million yuan, which will become a subsidiary after the transaction [7] - Guangju Energy is participating in the public transfer of an 8% stake in Shenzhen Mawan Power, aiming to increase its holding from 6.42% to 14.42% [8] - Zhongrong Marine plans to invest 2.58 billion yuan in Guangdong Yantian Port for a 20% stake through its wholly-owned subsidiary [15]

Group 1 - Cambridge Technology plans to invest 400 million yuan to establish a fund focused on optical devices and chips, aiming to invest in early-stage and growth-stage companies in the hard technology sector [1] - Tunnel Corporation's consortium won a bid for a highway project in Henan with a total investment of 6.49 billion yuan, using a BOT model for a 33.25-year cooperation period [2] - Hongrun Construction won a bid for a project worth 230 million yuan, which represents 3.88% of the company's projected revenue for 2024 [3] Group 2 - Tongrentang's product, Canling Baizhu Powder, received product registration approval from Health Canada, aimed at treating symptoms related to spleen and stomach weakness [4] - Hunan Baiyin announced a scheduled annual maintenance from December 9, 2025, to January 5, 2026, for equipment and facilities [5] - Changchun Gaoxin's subsidiary had two drugs included in the national medical insurance catalog for 2025 [6] Group 3 - Dongfang Securities' chairman resigned due to work relocation [7] - Xuantai Pharmaceutical's product, Sitagliptin Metformin Sustained-Release Tablets, was renewed for inclusion in the national medical insurance catalog [8] - ST Weihai was pre-selected for a smart agriculture EPC project with a bid of 652 million yuan, accounting for 26.27% of the company's projected revenue for 2024 [9] Group 4 - Guoxin Technology successfully tested an anti-quantum password financial POS chip, supporting both traditional and quantum-resistant algorithms [10] - Huaren Health's subsidiary received acceptance for a drug registration application for Lactulose Oral Solution, a common laxative [11] - Ankai Bus reported a 57.71% year-on-year increase in sales for the first 11 months of the year [12] Group 5 - Zhongyan Dadi's subsidiary won a bid for a project worth 73.86 million yuan [13] - Zhejiang Rongtai plans to invest 77 million USD in a factory in Thailand, focusing on mica paper and robot components production [14] - Optoelectronics plans to use up to 450 million yuan of idle funds for cash management [15] Group 6 - Tianyu Biological reported a 45.15% year-on-year decline in sales revenue from pig sales in November [16] - Daqin Railway's cargo transport volume increased by 1.75% year-on-year in November [17] - Yabo Co. won a bid for a heavy truck charging station project worth 3.616 million yuan [18] Group 7 - Hongri Pharmaceutical's product continues to be included in the national medical insurance catalog [19] - Jinggong Steel Structure signed a contract for steel structure installation worth approximately 470 million yuan for an overseas project [20] - Xizang Pharmaceutical's product, Xinhuasuan, continues to be included in the national medical insurance catalog [21] Group 8 - Guangdong Electric Power A announced the successful commissioning of a 1000MW unit at the Maoming Boge Power Plant [22] - Fuan Pharmaceutical's product, Palivizumab Injection, was newly included in the national medical insurance catalog [23] - Lizhu Group reported that 194 products were included in the 2025 national medical insurance catalog [24] Group 9 - Haisan Pharmaceutical's injection of Lantanol was included in the national medical insurance catalog [25] - Zhongtong Bus reported a 39.53% year-on-year increase in sales volume in November [26] - Shaanxi Coal Industry reported a 6.03% year-on-year increase in coal production in November [27] Group 10 - Haooubo's subsidiary received a medical device registration certificate for an IgG4 testing kit [28] - Yaopi Glass plans to invest 690 million yuan in new automotive glass production lines [30] - Huadian International completed the issuance of 2 billion yuan in medium-term notes [31] Group 11 - Zhongzai Zihuan's subsidiary won a bid for a green recycling project worth 205 million yuan [32] - Dabeinong reported a 25.26% year-on-year decline in sales revenue from pig sales in November [33] - Xiangjia Co. reported a 3.77% year-on-year increase in live poultry sales revenue in November [34] Group 12 - Huanxu Electronics reported a consolidated revenue of 5.198 billion yuan in November, a decrease of 3.34% year-on-year [35] - Aonong Biological reported a 72.21% year-on-year increase in pig sales volume in November [36] - Samsung Medical's subsidiary was pre-selected for a procurement project worth approximately 108 million yuan [37]

Group 1 - The commercial vehicle sector experienced a decline of 1.18% on December 8, with Yutong Bus leading the drop [1] - The Shanghai Composite Index closed at 3924.08, up 0.54%, while the Shenzhen Component Index closed at 13329.99, up 1.39% [1] - Key stocks in the commercial vehicle sector showed varied performance, with Shuguang Co. increasing by 1.46% and Yutong Bus decreasing by 2.06% [3] Group 2 - The net outflow of main funds in the commercial vehicle sector was 254 million yuan, while retail investors saw a net inflow of 136 million yuan [3][4] - Individual stock fund flows indicated that major stocks like FAW Jiefang and Jiangling Motors experienced significant net outflows from main funds [4] - The trading volume and turnover for various stocks in the sector varied, with Jianghuai Automobile having a turnover of 1.649 billion yuan [1][3]

人民财讯12月8日电，安凯客车（000868）12月8日公告，2025年11月销量为517辆；本年累计销量7570 辆，同比增长57.71%。 ...

安凯客车公告，2025年11月销量为517辆，本年累计销量7570辆，同比增长57.71%。其中，大型客车11 月销量76辆，本年累计销量3744辆，同比增长200.24%；中型客车11月销量371辆，本年累计销量2660 辆，同比增长30.07%；轻型客车11月销量70辆，本年累计销量1166辆，同比下降22.68%。产量方面， 2025年11月产量为869辆，本年累计产量7862辆，同比增长64.37%。其中，大型客车11月产量149辆， 本年累计产量3875辆，同比增长191.35%；中型客车11月产量459辆，本年累计产量2645辆，同比增长 38.99%；轻型客车11月产量261辆，本年累计产量1342辆，同比下降13.42%。 ...

单位：辆 证券代码：000868 证券简称：安凯客车 公告编号：2025-052 安徽安凯汽车股份有限公司 关于 2025 年 11 月份产销情况的自愿性信息披露公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 截至 2025 年 11 月份产销快报数据如下： | 品 目 | 2025 年 11 月 | 本年累计 | 累计数量较去年同期 增减比率 | | --- | --- | --- | --- | | 产量 | 869 | 7862 | 64.37% | | 其中：大型客车 | 149 | 3875 | 191.35% | | 中型客车 | 459 | 2645 | 38.99% | | 轻型客车 | 261 | 1342 | -13.42% | | 销量 | 517 | 7570 | 57.71% | | 其中：大型客车 | 76 | 3744 | 200.24% | | 中型客车 | 371 | 2660 | 30.07% | | 轻型客车 | 70 | 1166 | -22.68% | 本表为销售快报数据， ...

安凯客车（000868）(000868.SZ)披露2025年11月份产销情况，公司2025年11月各型车辆产量869辆，销 量517辆。 ...